Many evidence of liver cancer related to Chinese medicine was discovered

According to a scientific report published in the October 18 issue of the journal Science Translational Medicine, scientists have found evidence of a link between therapeutic methods of medicinal treatment. system and liver cancer in Asia.

The above report recommends stronger measures to prevent people from using aristolochic acids (AA).

These acids are found in some traditional Chinese remedies used during childbirth to fight infection and support post-natal recovery.

Need stronger measures to prevent people from using aristolochic acids (AA).

Scientists tested 98 liver tumors stored in Taiwan hospitals and found that 78% of them contained mutant samples that were more likely to result from further cancer. contact with the above chemicals.

Because the above acids cause a 'well-recognized characteristic mutation' , scientists also studied 89 samples of liver cancer in China and found that 47% of them were related to Traditional medicinal ingredients.

In 2003, Taiwan banned some remedies using these herbs after aristolochic acid detection could cause kidney failure and urethral cancer.

However, according to the above report, no absolute ban applies in China or Taiwan and authorities only regulate certain types of plants, not all types. Plants and products contain AA or its derivatives, making it difficult for users to prevent.

Scientists also found that the mutations associated with AA in liver cancer types in Taiwan did not decrease after the ban was implemented.

This may be because more time is needed to record changes in tracking data.

In addition, people may continue to interact with AA through other herbal products or mixtures containing these chemicals.